{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:57:08Z","timestamp":1794610628703,"version":"4.9.1"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi241136-4\"><jats:title>Importance<\/jats:title><jats:p>Layperson-administered naloxone (LAN) is a powerful but incompletely characterized intervention to prevent opioid-related overdose mortality. LAN trends are relevant to policy and strategic planning in naloxone distribution initiatives.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-5\"><jats:title>Objective<\/jats:title><jats:p>To assess the 2-year LAN trend for persons in the United States receiving naloxone during emergency medical services (EMS) activations.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This retrospective cross-sectional study was conducted in the United States from June 2020 to June 2022 among 65\u202f621\u202f195 EMS activations from 911 responses, EMS standbys, or when EMS crews functioned in an ambulance intercept role or during mutual aid to another ambulance response. Activations within health care settings and interfacility or medical transports were excluded. Data are from the National Emergency Medical Services Information System (NEMSIS), the national EMS patient care record database. From June 2020 to June 2022, NEMSIS included more than 96 million EMS activations from nearly 14\u202f000 agencies across 54 states and territories.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-7\"><jats:title>Exposures<\/jats:title><jats:p>EMS clinician\u2013reported LAN.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-8\"><jats:title>Main Outcome and Measures<\/jats:title><jats:p>The primary outcome was the trend of receiving LAN, measured by EMS clinician documentation.<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-9\"><jats:title>Results<\/jats:title><jats:p>From June 2020 to June 2022, EMS reported 744\u202f078 patients receiving naloxone, with 24\u202f990 (3.4%) involving LAN. Patients were predominantly male (17\u202f331 [69.4%]) and had a median (IQR) age of 42 (31-56) years, with the majority treated in urban homes or residences (21\u202f692 [86.8%] urban; 13\u202f223 [52.9%] in-home or residence). Of the total naloxone recipients, 243\u202f985 patients (32.8%) had suspected drug overdose documentation as either the primary or secondary impression. Overall, the percentage change in naloxone administration rates decreased 6.1% over the study period (from 1140.1 [95% CI, 1135.1-1145.1] per 100\u202f000 EMS activations to 1070.1 [95% CI, 1064.9-1075.3] per 100\u202f000 EMS activations), while the percentage change of persons receiving LAN increased 43.5% (from 30.0 [95% CI, 29.2-30.8] per 100\u202f000 EMS activations to 43.1 [95% CI, 42.0-44.1] per 100\u202f000 EMS activations).<\/jats:p><\/jats:sec><jats:sec id=\"ab-zoi241136-10\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>In this cross-sectional study, the LAN rate increased from June 2020 to June 2022 as reported in the national EMS database. These findings help inform policies and practices aimed at mitigating the devastating impacts of the opioid epidemic and saving lives. Novel public health strategies are needed to measure the effects of this intervention nationally, evaluate approaches to expand naloxone distribution, and address naloxone usage barriers.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.39427","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:01:13Z","timestamp":1728918073000},"page":"e2439427","source":"Crossref","is-referenced-by-count":30,"title":["Layperson-Administered Naloxone Trends Reported in Emergency Medical Service Activations, 2020-2022"],"prefix":"10.1001","volume":"7","author":[{"given":"Christopher B.","family":"Gage","sequence":"first","affiliation":[{"name":"Division of Epidemiology, The Ohio State University College of Public Health, Columbus"},{"name":"National Registry of Emergency Medical Technicians, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Powell","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, The Ohio State University College of Public Health, Columbus"},{"name":"National Registry of Emergency Medical Technicians, Columbus, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Ulintz","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca E.","family":"Cash","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Lyons","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish R.","family":"Panchal","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, The Ohio State University College of Public Health, Columbus"},{"name":"National Registry of Emergency Medical Technicians, Columbus, Ohio"},{"name":"Department of Emergency Medicine, The Ohio State University, Columbus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,10,14]]},"reference":[{"key":"zoi241136r4","doi-asserted-by":"publisher","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep","DOI":"10.15585\/mmwr.mm6935a1"},{"key":"zoi241136r5","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"7","key":"zoi241136r6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1592\/phco.30.7.627","article-title":"Opioid harm reduction strategies: focus on expanded access to intranasal naloxone.","volume":"30","author":"Wermeling","year":"2010","journal-title":"Pharmacotherapy"},{"issue":"9596","key":"zoi241136r8","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"issue":"4","key":"zoi241136r12","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/10903127.2022.2079779","article-title":"Description of the 2020 NEMSIS public-release research dataset.","volume":"27","author":"Ehlers","year":"2023","journal-title":"Prehosp Emerg Care"},{"key":"zoi241136r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.resuscitation.2023.110024","author":"Gage","year":"2023","journal-title":"Resuscitation"},{"issue":"2","key":"zoi241136r16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1080\/10903127.2021.2018076","article-title":"Differences in out-of-hospital cardiac arrest management and outcomes across urban, suburban, and rural settings.","volume":"27","author":"Peters","year":"2023","journal-title":"Prehosp Emerg Care"},{"issue":"31","key":"zoi241136r17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.15585\/mmwr.mm6731a2","article-title":"Naloxone administration frequency during emergency medical service events\u2014United States, 2012-2016.","volume":"67","author":"Cash","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"50-51","key":"zoi241136r18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"zoi241136r22","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014.","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi241136r24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2020.100474","article-title":"Layperson reversal of opioid overdose supported by smartphone alert: a prospective observational cohort study.","volume":"25","author":"Schwartz","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"6","key":"zoi241136r25","doi-asserted-by":"publisher","first-page":"952","DOI":"10.5811\/westjem.2022.8.56561","article-title":"Implementation of a leave-behind naloxone program in San Francisco: a one-year experience.","volume":"23","author":"LeSaint","year":"2022","journal-title":"West J Emerg Med"},{"issue":"3","key":"zoi241136r26","doi-asserted-by":"publisher","DOI":"10.1002\/emp2.13186","article-title":"At-risk patient documentation and naloxone dispersal for a rural statewide EMS Naloxone Leave Behind program.","volume":"5","author":"Naumann","year":"2024","journal-title":"J Am Coll Emerg Physicians Open"},{"issue":"3","key":"zoi241136r27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1080\/10903127.2020.1771490","article-title":"Best practices for a novel EMS-based naloxone leave behind program.","volume":"25","author":"Scharf","year":"2021","journal-title":"Prehosp Emerg Care"},{"issue":"8","key":"zoi241136r28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0289959","article-title":"Evaluation of a large-scale health department naloxone distribution program: per capita naloxone distribution and overdose morality.","volume":"18","author":"Freiermuth","year":"2023","journal-title":"PLoS One"},{"issue":"3","key":"zoi241136r29","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1360-0443.2005.00975.x","article-title":"Calling emergency medical services during drug overdose: an examination of individual, social and setting correlates.","volume":"100","author":"Tobin","year":"2005","journal-title":"Addiction"},{"issue":"6","key":"zoi241136r30","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1080\/10903127.2017.1335818","article-title":"Incidence of naloxone redosing in the age of the new opioid epidemic.","volume":"21","author":"Klebacher","year":"2017","journal-title":"Prehosp Emerg Care"},{"issue":"2","key":"zoi241136r31","doi-asserted-by":"publisher","first-page":"e1921227","DOI":"10.1001\/jamanetworkopen.2019.21227","article-title":"Availability of naloxone at rural Georgia pharmacies, 2019.","volume":"3","author":"Nguyen","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi241136r20","year":"2023"},{"key":"zoi241136r1","unstructured":"US Department of Health and Human Services. Surgeon General releases advisory on naloxone, an opioid overdose-reversing drug. April 5,2018. Accessed September 9, 2024. https:\/\/www.hiv.gov\/blog\/surgeon-general-releases-advisory-naloxone-opioid-overdose-reversing-drug"},{"key":"zoi241136r2","unstructured":"National Institute on Drug Abuse. Drug overdose death rates. Accessed July 16, 2024. https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates#:~:text=Drug%20overdose%20deaths%20involving%20any,among%20males%20(Figure%203)"},{"key":"zoi241136r3","unstructured":"US Centers for Disease Control and Prevention. Understanding the opioid overdose epidemic. Accessed July 16, 2024. https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html"},{"key":"zoi241136r7","unstructured":"Center for Public Health Law Research. Naloxone overdose prevention laws. Accessed March 22, 2024. https:\/\/pdaps.org\/datasets\/laws-regulating-administration-of-naloxone-1501695139"},{"key":"zoi241136r9","unstructured":"National Emergency Medical Information System (NEMSIS). What is NEMSIS? Accessed February 25, 2021. https:\/\/nemsis.org\/what-is-nemsis\/"},{"key":"zoi241136r10","unstructured":"National Emergency Medical Information System (NEMSIS). 2022 NEMSIS public-release research dataset now available. Accessed March 22, 2024. https:\/\/nemsis.org\/2022-nemsis-public-release-research-dataset-now-available\/"},{"key":"zoi241136r11","unstructured":"National Emergency Medical Information System (NEMSIS). 2022 NEMSIS public release research dataset flyer 1. Accessed July 18, 2023. https:\/\/nemsis.org\/wp-content\/uploads\/2023\/04\/Banner-Template-Dataset-2023-Recovered2-01a.png"},{"key":"zoi241136r13","unstructured":"National Emergency Medical Information System (NEMSIS). Nonfatal drug overdose surveillance dashboard companion guide. Accessed July 11, 2024, 2024. https:\/\/wiki.utahdcc.org\/confluence\/display\/NTD\/Drug+Overdose+Surveillance+Dashboard+Companion+Guide"},{"key":"zoi241136r14","unstructured":"Centers for Disease Control and Prevention. Wide-ranging online data for epidemiologic research (WONDER). Accessed March 23, 2024. https:\/\/wonder.cdc.gov\/"},{"key":"zoi241136r19","unstructured":"National Cancer Institute. Empirical quantile confidence interval. Accessed September 9, 2024. https:\/\/surveillance.cancer.gov\/help\/joinpoint\/setting-parameters\/method-and-parameters-tab\/apc-aapc-tau-confidence-intervals\/empirical-quantile"},{"key":"zoi241136r21","unstructured":"US Government Accountability Office. Drug misuse: most states have Good Samaritan laws and research indicates they may have positive effects. March 29, 2021. Accessed September 9, 2024. https:\/\/www.gao.gov\/products\/gao-21-248"},{"key":"zoi241136r23","unstructured":"National Institute on Drug Abuse. Naloxone for opioid overdose: life-saving science. Accessed March 22, 2024. https:\/\/archives.nida.nih.gov\/publications\/naloxone-opioid-overdose-life-saving-science"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2824732\/gage_2024_oi_241136_1727892285.0671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T15:01:16Z","timestamp":1728918076000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2824732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,14]]},"references-count":31,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.39427","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,14]]}}}